Ani Pharmaceuticals Inc (ANIP) — SC 13D/A Filings
All SC 13D/A filings from Ani Pharmaceuticals Inc. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Meridian Venture Partners Boosts ANI Pharma Stake
— Mar 14, 2024 Risk: medium
Meridian Venture Partners II, L.P. and its affiliates, including Robert E. Brown, Jr., have amended their Schedule 13D filing for ANI Pharmaceuticals, Inc. as o -
Esjay LLC Amends ANI Pharma Stake, Signals Ownership Change
— Jan 17, 2024
Esjay LLC, a major shareholder in ANI Pharmaceuticals Inc., filed an amendment to its Schedule 13D on January 17, 2024, indicating a change in its beneficial ow
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX